The secretion of IL-12 or IL-18 by CAR T cells may be able to raise local concentrations of these cytokines within the TME, potentially enhancing CAR T cell function itself, as well as creating a more favourable immune landscape within the tumour. This evidence concerns the gene IL18 and neoplasm.